Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 2,001,852 shares at $8.93 ($15.7M) on 2024-05-31, disclosed to the SEC on 2024-06-04.
Open-market sale of $15.7M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 716,573 | $5.6M | 35.6% |
| 2 | $7.78 | 716,573 | $5.6M | 35.6% |
| 3 | $8.93 | 93,213 | $832K | 5.3% |
| 4 | $8.93 | 93,213 | $832K | 5.3% |
| 5 | $7.42 | 190,214 | $1.4M | 9.0% |
| 6 | $7.42 | 190,214 |
| $1.4M |
| 9.0% |
| 7 | $7.28 | 1,852 | $13K | 0.1% |
| Total | $7.82 avg | 2,001,852 | $15.7M | 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |